Abstract
While psychiatric disorder prevalence is higher among patients living with HIV (PLWH), there are no prior studies on rates of psychiatric diagnosis documentation in electronic medical records (EMRs) of PLWH, which was the goal of this study. Participants (n = 2,336) were enrolled in the Center for AIDS Research (CFAR) Longitudinal Database study. Diagnostic codes were extracted to assess the prevalence rates of depressive, alcohol/substance use, PTSD, sleep, and adjustment disorders. Prevalence rates for psychiatric disorders were extracted from national epidemiological studies for comparison. Rates of Major Depressive Disorder in the EMR were comparable to prior epidemiological reports in PLWH. In contrast, rates of PTSD, substance use, alcohol use, adjustment, and insomnia disorders were all markedly lower compared to epidemiological studies. While clinicians appropriately documented depression, other psychiatric comorbidities were largely overlooked. This indicates a potential bias in the detection or documentation of psychiatric disorders in PLWH.
Keywords: HIV, Mental Illness, Electronic Medical Records, Major Depression, PTSD
INTRODUCTION
Persons living with HIV (PLWH) are significantly more likely to meet criteria for a psychiatric diagnosis compared to the general population (1–2). While prevalence estimates vary, up to 50% PLWH are estimated to meet criteria for a psychiatric disorder in their lifetime (3). The most common psychiatric comorbidities among PLWH are substance use disorders, depression, posttraumatic stress disorder (PTSD), and anxiety disorders (4).
The consequences of psychiatric comorbidity among PLWH are serious. Psychiatric comorbidities are associated with poor adherence to anti-retroviral therapies (ART), which reduces the likelihood of achieving viral load suppression (5–6). PLWH who have a psychiatric comorbidity are more likely to die by suicide compared to PLWH without a psychiatric diagnosis (7). The presence of a psychiatric diagnosis contributes to early all-cause mortality among PLWH (8). Finally, psychiatric comorbidities among PLWH may contribute to the enormous economic burden association with HIV infection (9).
Fortunately, evidence-based practices (EBPs) are extremely effective at reducing psychiatric symptoms among PLHW, thereby reducing the burden of illness. For example, in a randomized controlled trial, Safren and colleagues (10) found that cognitive behavioral therapy (CBT) led to significantly greater reductions in depression and significantly better treatment adherence relative to treatment as usual in PLWH. Similarly, PLWH had significantly greater reductions in PTSD symptoms in response to prolonged exposure (PE) therapy for PTSD compared to a monitoring condition and these gains were maintained up to 6 months after treatment termination (11). In terms of substance use symptoms, a pilot of PLWH who had a substance use disorder found that CBT was associated with significant reductions in alcohol use and depression (12). Therefore, CBT is effective for a variety of psychiatric comorbidities among PLWH.
While there is overwhelming evidence that psychiatric conditions can be mitigated among PLWH, receipt of evidence-based practice is contingent upon accurate diagnosis. In busy and under-resourced medical settings, a variety of logistical and psychological factors may prevent the detection and documentation of psychiatric disorders. For instance, the stigma of mental illness (13) may dissuade a provider from documenting a psychiatric disorder among PLWH, who are already at higher risk for stigma (14). Without a psychiatric diagnosis, PLWH are unlikely to receive a referral for EBPs or to recover from their illness (15). It is essential to understand the frequency of detection and documentation of mental health conditions among PLWH in clinical practice.
Electronic medical records (EMRs) provide a useful tool for understanding documentation of psychiatric illness among PLWH in care. While national epidemiological studies demonstrate that psychiatric disorder prevalence is higher among PLWH, to our knowledge there are no prior studies that report rates of psychiatric diagnoses documentation in EMRs of PLWH. This is a critical gap in the literature that requires research to inform implementation of evidence-based practice for psychiatric disorders of PLWH.
The goal for this study was to report the rates of a variety psychiatric diagnoses among PLWH in EMRs. More specifically, we sought to explore the frequency of diagnosis of major depressive disorder, posttraumatic stress disorder (PTSD), insomnia, alcohol use disorders, and substance use disorders in EMRs for a large sample of PLWH. These disorders were selected because they are some of the most commonly reported psychiatric conditions among PLWH (16–18). We then aimed to compare these rates to prevalence estimates of these psychiatric conditions from epidemiological studies of the general population and of PLWH. Based on prior research on stigma of psychiatric diagnoses (13), we hypothesized that rates of documentation of psychiatric disorders would be lower in the EMR compared to epidemiological estimates of PLWH and the general population.
METHODS
Participants.
Participants (n = 2,336) were participants in the Center for AIDS Research (CFAR) Longitudinal Database study at the University of Pennsylvania, Philadelphia, PA. Demographic information and diagnostic code frequencies are reported in Table I. All CFAR Participants in this study were HIV positive and provided informed consent allowing for the extraction of their EMR data.
Table I.
Demographic Information
| n (%) | |
|---|---|
| Gender | |
| Male | 1,704 (73.0) |
| Female | 632 (27.1) |
| Age, M (SD) | 52.8 (11.4) |
| Marital Status | |
| Single | 1,798 (77.0) |
| Separated | 56 (2.4) |
| Divorced | 121 (5.1) |
| Widowed | 48 (2.1) |
| Married | 313 (13.4) |
| Ethnicity | |
| Black/African American | 1,474 (63.1) |
| White | 776 (33.2) |
| Asian | 9 (0.4) |
| Native Hawaiian/Pacific Islander | 2 (0.0) |
| Other | 48 (2.1) |
| “Unknown” | 26 (1.1) |
| Missing | 1 (0.0) |
| Race | |
| Hispanic/Latino | 104 (4.5) |
| Non-hispanic/Non-Latino | 2,167 (92.8) |
| Missing | 65 (2.8) |
| Psychiatric Disorders | |
| Adjustment-Related Disorders (309.9, F43.20–29) | 103 |
| Stress-Related Disorders/PTSD (309.81, F43.0–10) | 98 |
| Alcohol-Related Disorders (F10.10–951) | 168 |
| Cannabis-Related Disorders (F12.10–90) | 34 |
| Cocaine-Related Disorders (F14.10–929) | 136 |
| Hallucinogen-Related Disorders (F16.10–929) | 7 |
| Depression (301.12, F32.0–34.1) | 771 |
| Opioid-Related Disorders (F11.10–229) | 81 |
| Other Psychoactive Substance Related Disorders (F19.10–981) | 91 |
| Sedative-Related Disorders (F13.10–239) | 10 |
| Sleep-Related Disorders (F51.01–12, G47.00–419, Z72.280) | 499 |
Note: Psychiatric disorder frequency include participants who met criteria for multiple diagnoses within a category (i.e., multiple sleep-related disorders) as well as those who only met one within a category. Therefore these values cannot be used for prevalence rates. However, Table II data reports frequencies with any dual-diagnosis individuals counted only once per category as an indication of prevalence.
Diagnostic Codes.
Diagnostic codes were extracted to assess the prevalence of depressive disorders, alcohol and substance use disorders, PTSD, sleep disorders, and adjustment disorders (see Supplemental Table I) for all CFAR participants.
Prevalence Rate Comparisons.
Prevalence rates for psychiatric disorders were extracted from national epidemiological studies for these diagnoses. All studies used for prevalence rate comparisons are cited in the footnote for Table II.
Table II.
Prevalence Rates in National Surveys in the General Population, HIV positive population, and in the electronic medical record.
| Disorder | General Population Lifetime Prevalence (%) | HIV+ Population | Electronic Medical Record Prevalence |
|---|---|---|---|
| Major Depression | 16.2 | 15.8–22 | 19.3 (Including other depressive disorders: 20.6) |
| PTSD | 6.8 | 30–42 | 2.6 (Including other trauma disorders: 3.5) |
| Adjustment Disorders | 1–2 | 25.9 | 3.9 |
| Insomnia | 6.0 | 38-47-67-73 | 7.5 (Including other sleep disorders: 14.1) |
| Alcohol Abuse | 13.2 | 8–10.9 | 2.4 (Including all alcohol use disorders: 4.5) |
| Substance Abuse | 7.9 | 19.6–21 | 3.3 (Including all substance use disorders: 7.6) |
Extraction Procedures.
The University of Pennsylvania maintains a research repository of electronic health information that is compiled from multiple University of Pennsylvania Health System (UPHS) clinical information databases and is updated daily. This repository was used to query all hospital encounter records for participants enrolled in the CFAR registry to identify occurrences of the diagnoses of interest. Extracted data sets identified participants using only CFAR registry participant IDs to protect participant confidentiality.
RESULTS
Compared to the general population, rates of Major Depressive Disorder and insomnia were slightly higher in the sample from the EMRs. In contrast, PTSD, substance use disorders, alcohol use disorders, and adjustment disorders were all lower in the EMR sample compared to national prevalence estimates for the general population.
Rates of Major Depressive Disorder (MDD) in the electronic medical record were comparable to prior reports on HIV-infected samples. In contrast, rates of PTSD, substance use disorders, alcohol use disorders, adjustment disorders and insomnia from the EMR were all reported at markedly lower rates compared to prevalence estimates for HIV-infected samples in the literature.
DISCUSSION
Documentation of most psychiatric disorders was lower in EMRs of PLWH compared to population and HIV-specific prevalence estimates. For some disorders, including substance use disorders, PTSD and insomnia, rates were about 10 times lower in the chart compared to prior literature. Of the disorders sampled, MDD was the only disorder that was documented at expected rates. These findings suggest a potential bias in how clinicians either detect or document psychiatric disorders in PLWH.
In epidemiological studies, rates of psychiatric disorders are consistently higher among PLWH compared to the general population (1–2). In contrast, we found evidence for lower reporting of many psychiatric disorders among PLWH compared to the general population. While clinicians are appropriately documenting evidence of MDD, other psychiatric comorbidities are being largely overlooked.
Sufficient documentation of MDD was somewhat surprising in light of under-documentation for all other psychiatric disorders. However, appropriate documentation of depression among PLWH may be a relatively new phenomenon, as older reports found lower rates of depression documentation among individuals with AIDS compared to individuals without AIDS (19). This finding suggests that clinicians are increasing detection and documentation of depression among PLWH, perhaps because of improved awareness of effective treatments for MDD, including CBT. These findings also raise the possibility that clinicians recognize the psychological impact of HIV-infection, but tend to be biased in their detection and documentation of MDD to the exclusion of other psychiatric comorbidities. This may be due to a lack of recognition of the effectiveness of other EBPs for other disorders, In the general population, primary care physicians tend to over-diagnose MDD, especially among patients with lower psychosocial functioning (20–21). Furthermore, among PLWH, scores of measures of MDD may be inflated due to overlapping somatic symptoms between depression and HIV-infection (22). To improve documentation across psychiatric conditions, efforts should focus on educating clinicians about the complex psychological impact of HIV-infection4 as well as on psychiatric predictors of acquiring HIV-infection (23–24).
The consequences of under-documentation of psychiatric disorders among PLWH are enormous. PLWH are unlikely to receive referrals for mental health treatment if their psychiatric illnesses are not documented. This is of major importance, because PLWH already receive suboptimal rates of mental health care (25). When untreated, psychiatric illnesses such as PTSD are unlikely to spontaneously remit (15). Furthermore, psychiatric comorbidities contribute to poor adherence to antiretroviral therapies (5–6, 26), and are therefore less likely to achieve virologic suppression (6,27). Psychiatric comorbidities also contribute to early mortality among PLWH (28); for instance, among individuals who have achieved immunovirologic success, suicide is the second leading cause of death (29). Therefore, under-documentation of psychiatric illness among PLWH is an overlooked challenge to achieving 90-90-90 targets (30). This is an issue in need of immediate correction. One corrective action that could improve detection and documentation of psychiatric illness about PLWH is to mandate continuing education in EBPs for psychiatric disorders for clinicians treating PLWH.
One limitation is that we did not extract a random sample of non-HIV-infected comparison cases. Therefore, we are unable to determine whether the findings are of relevance to EMR documentation more broadly versus under-documentation for PLWH specifically. Future research should directly compare EMR documentation of PLWH to non-HIV-infected comparisons. Another limitation is that all participants were involved in ongoing studies through the Penn Center for AIDS Research (CFAR). Participants in this particular cohort not may be unrepresentative of the entire population of HIV-infected individuals treated through Penn or of the HIV population generally. However, participation in the Penn CFAR studies may provide improved access to care, which might lead to increased documentation of comorbidities. Therefore, documentation rates in this sample may be higher compared to the general population of HIV-infected individuals.
CONCLUSIONS
In summary, this is the first study of its kind to demonstrate remarkable underreporting of psychiatric conditions in EMRs of PLWH. Receipt of psychiatric treatment is critical to the 90-90-90 targets. In order for PLWH to receive psychiatric treatment, they must be properly diagnosed with any relevant psychiatric conditions. These findings indicate a need for strategies to enhance psychiatric diagnosis detection and documentation among PLWH.
Supplementary Material
ACKNOWLEDGEMENTS
This publication resulted (in part) from research supported by the Mid-Atlantic CFAR Consortium (MACC) Scholars Program, an inter-CFAR collaboration between the District of Columbia Center for AIDS Research (P30 AI117970), the University of Pennsylvania CFAR (P30 A1 045008), and the Johns Hopkins University CFAR (P30 A1 094189). This collaboration is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
REFERENCES
- 1.Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–728. [DOI] [PubMed] [Google Scholar]
- 2.Dew MA, Becker JT, Sanchez J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med. 1997;27(2):395–409. [DOI] [PubMed] [Google Scholar]
- 3.Gaynes BN, Pence BW, Eron JJ Jr., et al. Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med. 2008;70(4):505–511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Nedelcovych MT, Manning AA, Semenova S, et al. The Psychiatric Impact of HIV. ACS Chem Neurosci. 2017;8(7):1432–1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–2143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Delahanty DL, Bogart LM, Figler JL. Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals. AIDS Care. 2004;16(2):247–260. [DOI] [PubMed] [Google Scholar]
- 7.Hentzien M, Cabie A, Pugliese P, et al. Factors associated with deaths from suicide in a French nationwide HIV-infected cohort. HIV Med. 2018. [DOI] [PubMed] [Google Scholar]
- 8.DeLorenze GN, Satre DD, Quesenberry CP, et al. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS. 2010;24(11):705–712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lopez-Bastida J, Oliva-Moreno J, Perestelo-Perez L, et al. The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain. BMC Health Serv Res. 2009;9:55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Safren SA, O’Cleirigh CM, Bullis JR, et al. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pacella ML, Armelie A, Boarts J, et al. The impact of prolonged exposure on PTSD symptoms and associated psychopathology in people living with HIV: a randomized test of concept. AIDS Behav. 2012;16(5):1327–1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Esposito-Smythers C, Brown LK, Wolff J, et al. Substance abuse treatment for HIV infected young people: an open pilot trial. J Subst Abuse Treat. 2014;46(2):244–250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Purvis B, Brandt R, Rouse C, et al. Students’ attitudes toward hypothetical chronically and acutely mentally and physically ill individuals. Psychol Rep. 1988;62(2):627–630. [DOI] [PubMed] [Google Scholar]
- 14.Laryea M, Gien L. The impact of HIV-positive diagnosis on the individual, Part 1: stigma, rejection, and loneliness. Clin Nurs Res. 1993;2(3):245–263. [DOI] [PubMed] [Google Scholar]
- 15.Bremner JD, Southwick SM, Darnell A, et al. Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry. 1996;153(3):369–375. [DOI] [PubMed] [Google Scholar]
- 16.Whetten K, Leserman J, Lowe K, et al. Prevalence of childhood sexual abuse and physical trauma in a southern HIV positive sample from the Deep South. Am J Public Health. 2006;96(6):1028–1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Goulet J, Fultz S, Rimland D, et al. Do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45(12):1593–1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kilbourne AM, Justice AC, Rabeneck L, et al. General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol. 2001;54(12):S22–S28. [DOI] [PubMed] [Google Scholar]
- 19.Bialer PA, Wallack JJ, Prenzlauer SL, et al. Psychiatric comorbidity among hospitalized AIDS patients vs. non-AIDS patients referred for psychiatric consultation. Psychosomatics. 1996;37(5):469–475. [DOI] [PubMed] [Google Scholar]
- 20.Aragones E, Pinol JL, Labad A. The overdiagnosis of depression in non-depressed patients in primary care. Fam Pract. 2006;23(3):363–368. [DOI] [PubMed] [Google Scholar]
- 21.Mbada CE, Onayemi O, Ogunmoyole Y, et al. Health-related quality of life and physical functioning in people living with HIV/AIDS: a case-control design. Health Qual Life Outcomes. 2013;11:106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188(10):662–670. [DOI] [PubMed] [Google Scholar]
- 23.DeBeck K, Kerr T, Li K, et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. CMAJ. 2009;181(9):585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Brown LK, Danovsky MB, Lourie KJ, et al. Adolescents with psychiatric disorders and the risk of HIV. J Am Acad Child Adolesc Psychiatry. 1997;36(11):1609–1617. [DOI] [PubMed] [Google Scholar]
- 25.Ashman JJ, Conviser R, Pounds MB. Associations between HIV-positive individuals’ receipt of ancillary services and medical care receipt and retention, AIDS Care. 2002; 14(Suppl 1): 109–118. [DOI] [PubMed] [Google Scholar]
- 26.Tucker JS, Burnam MA, Sherbourne CD, et al. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114(7):573–580. [DOI] [PubMed] [Google Scholar]
- 27.Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2005;38(3):320–328. [PubMed] [Google Scholar]
- 28.Mills JC, Pence BW, Todd JV, et al. Cumulative burden of depression and all-cause mortality in women living with human immunodeficiency virus. Clin Infect Dis. 2018;67(10):1575–1581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Goehringer F, Bonnet F, Salmon D, et al. Causes of death in HIV-infected individuals with immunovirologic success in a national prospective survey. AIDS Res Hum Retroviruses. 2016;33(2):187–193. [DOI] [PubMed] [Google Scholar]
- 30.UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. 2014.
- 31.Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602. [DOI] [PubMed] [Google Scholar]
- 32.Maercker A, Forstmeier S, Pielmaier L, et al. Adjustment disorders: prevalence in a representative nationwide survey in Germany. Soc Psychiatry Psychiatr Epidemiol. 2012;47(11):1745–1752. [DOI] [PubMed] [Google Scholar]
- 33.Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. [DOI] [PubMed] [Google Scholar]
- 34.Pence BW, Miller WC, Whetten K, et al. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298–306. [DOI] [PubMed] [Google Scholar]
- 35.Orlando M, Burnam MA, Beckman R, et al. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res. 2002;11(2):75–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Theuninck AC, Lake N, Gibson S. HIV-related posttraumatic stress disorder: investigating the traumatic events. AIDS Patient Care STDS. 2010;24(8):485–491. [DOI] [PubMed] [Google Scholar]
- 37.Machtinger EL, Wilson TC, Haberer JE, et al. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16(8):2091–2100. [DOI] [PubMed] [Google Scholar]
- 38.Martinez A, Israelski D, Walker C, et al. Posttraumatic stress disorder in women attending human immunodeficiency virus outpatient clinics. AIDS Patient Care STDS. 2002;16(6):283–291. [DOI] [PubMed] [Google Scholar]
- 39.Crum-Cianflone NF, Roediger MP, Moore DJ, et al. Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis. 2012;54(10):1485–1494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–789. [DOI] [PubMed] [Google Scholar]
- 41.Rubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(3):260–265. [DOI] [PubMed] [Google Scholar]
- 42.Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63(2):179–186. [DOI] [PubMed] [Google Scholar]
- 43.Wu J, Wu H, Lu C, et al. Self-reported sleep disturbances in HIV-infected people: a meta-analysis of prevalence and moderators. Sleep Med. 2015;16(8):901–907. [DOI] [PubMed] [Google Scholar]
- 44.Allavena C, Guimard T, Billaud E, et al. Prevalence and risk factors of sleep disturbances in a large HIV-infected adult population. J Int AIDS Soc. 2014;17(4S3):19576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Dowrick C, Casey P, Dalgard O, et al. Outcomes of Depression International Network (ODIN). Background, methods and field trials. ODIN Group. Br J Psychiatry. 1998;172:359–363. [DOI] [PubMed] [Google Scholar]
- 46.Lee KA, Gay C, Portillo CJ, et al. Types of sleep problems in adults living with HIV/AIDS. J Clin Sleep Med. 2012;8(1):67–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
